Elliott Investment Management has significantly increased its stake in Align Technology Inc., the maker of Invisalign clear aligners, according to Bloomberg Markets. This move comes as Align reports robust growth in its core teeth-straightening business, with Invisalign sales rising 12% year-over-year to $2.1 billion in the latest quarter. The hedge fund's substantial investment positions it as Align's largest shareholder, potentially influencing strategic decisions. Align Technology dominates the clear aligner market, holding over 70% share against competitors like 3M's AlignerCo. The stake increase suggests Elliott believes Align can maintain pricing power amid rising dental insurance reimbursement rates and expanding patient adoption.

This development may encourage other investors to reassess Align's valuation, currently trading at 12x forward earnings. Elliott's involvement could signal confidence in Align's ability to navigate regulatory scrutiny around dental device approvals and capitalize on the shift toward at-home orthodontic solutions.